Aviscumine

N/A

Report date: 2022/04/19 14:27:28

Base Information

Drug NameAviscumine
Drug Alias Name阿维库明Viscum ribosome inactivating proteinRecombinant mistletoe lectinMistletoe lectin recombinantRecombinant viscumine +[12] 
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of Action28S rRNA inhibitors
Targets28S rRNA
Therapy Area/IndicationsSolid tumoursColorectal NeoplasmsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustriaGermanyFrance
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesViscum Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Medical Center FreiburgCytavis Biopharma GmbhUniversity Hospital Freiburg Eye Center +[4] 
Active IndicationsN/A
Inactive IndicationsSolid tumoursColorectal NeoplasmsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A